OTC · Biotechnology

Gemina Laboratories Ltd. (GLABF) Stock

$0.05 +0.00% OTC: GLABF Healthcare

Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions.

Valuation

MetricValue
Price$0.05
Market Cap$3.83M
P/E Ratio-1.54
P/B Ratio-0.89
P/S Ratio422.34
EPS (TTM)$-0.03
52-Week High$0.55
52-Week Low$0.04
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE62.39%
ROA-263.70%
ROCE55.22%
Gross Margin-496.49%
Operating Margin-26104.50%
Net Margin0.00%
Debt/Equity-0.05
Current Ratio0.01

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-5.0M$-6.0M$-5.0M$-4.0M$-2.0M
Net Profit$-5.0M$-6.0M$-5.0M$-4.0M$-2.0M
EPS$-0.10$-0.10$-0.07$-0.05$-0.03
Op Margin————-10407.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$2.0M$1.0M$1.0M$2.0M
Total Liabilities$0$2.0M$3.0M$6.0M$8.0M
Cash$1.0M$0$0$0$0
Borrowings$0$0$0$1.0M$1.0M

Latest News

Gemina Announces Private Placement Offering ACCESS Newswire · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-3.0M$-1.0M$-1.0M
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$2.0M$0$0$0$0
Net Cash Flow$0$-1.0M$0$0$0
Free Cash Flow$-4.0M$-5.0M$-3.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.16
EV / EBITDA-1.74
FCF Yield0.01%
Quick Ratio0.01
Interest Coverage-34.57
Return 1Y-90.35%
Return 3Y-90.74%
Return 5Y—

Ownership

Insiders Held44.72%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACMSYAccuStem Sciences Limited $0.13 -7.14% -1.08 $0 0.00%
CLCSCell Source, Inc. $0.80 -6.98% -8.00 $36.03M 0.00%
HMTXFHemostemix Inc $0.05 -14.81% -2.53 $9.22M 0.00%
PPCB $1.01 -2.88% 0.00 $883115 0.00%
PRVCFPreveCeutical Medical Inc. $0.01 +12.00% -5.00 $8.37M 0.00%

About Gemina Laboratories Ltd.

Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections. The company maintains its corporate headquarters in Vancouver, Canada.

Gemina Laboratories Ltd. is headquartered in CA.

Gemina Laboratories Ltd. (GLABF) stock trades at $0.05 with a market capitalization of $3.83M. The stock is valued at a price-to-earnings (P/E) ratio of -1.54, price-to-book of -0.89, price-to-sales of 422.34. Over the past 52 weeks the stock has ranged between $0.04 and $0.55, and currently trades 90.9% below its 52-week high.

On profitability, Gemina Laboratories Ltd. generates a return on equity (ROE) of 62.39% — well above the market average, a sign of a high-quality business, return on capital employed of 55.22%, an operating margin of -26104.50%, a net profit margin of 0.00%.

Official website: www.geminalabs.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides